Showing 1,095 results

Filters Content type: News, Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

Health Department Announces Plan to Combat Hepatitis C

Editor's pick
New York City Department of Health and Mental Hygiene (press release)
8 October 2013
Hepatitis C transmission & prevention

Is HCV infection spreading among HIV-positive gay men in Japan?

News
4 October 2013
Hepatitis C treatment

New publication: "Management of tuberculosis and HIV coinfection"

Editor's pick
WHO Europe
27 September 2013
Hepatitis C treatment

Simeprevir has been approved in Japan for the treatment of genotype 1 chronic hepatitis C infection

Editor's pick
Medivir press release
27 September 2013
Hepatitis C treatment

Treating HCV genotypes 2 and 3 in HIV/HCV co-infected people

News
27 September 2013
Hepatitis C treatment

Interferon response reduces liver disease and death in HIV/HCV co-infected people

News
19 September 2013
Hepatitis C treatment

Hepatitis C treatment cost in Ukraine will be reduced by half

Editor's pick
Ukrainian Community Advisory Board
17 September 2013
Hepatitis C treatment

Alliance Ukraine Brokers Deal for Significant Reduction in Cost of HCV Treatment

Editor's pick
Global Fund Observer
11 September 2013
Access to healthcare

Protest action in front of the Russian Ministry of Health “TO TREAT HEPATITIS C? CHEAPER TO BURY…”

Editor's pick
Andrei Rylkov Foundation for Health and Social Justice
5 September 2013
Hepatitis C treatment

The State will finance the Hepatitis C treatment for the first time ever

Editor's pick
Ukrainian Community Advisory Board
4 September 2013
Hepatitis C treatment

People with HIV/HCV-co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease

News
2 September 2013
New & experimental hepatitis C treatment

FDA, academia and industry team up to end hepatitis C

Editor's pick
University of Florida press release
30 August 2013
Activism & civil society

World Hepatitis Day - Actions Worldwide

Editor's pick
HepCoalition
7 August 2013
New & experimental hepatitis C treatment

Physicians are Foregoing Treatment of Their HCV Patients Until New Agents Become Available

Editor's pick
BioTrends
6 August 2013
Hepatitis C treatment

A quarter of HIV/HCV-co-infected people in EuroSIDA have received HCV therapy

News
6 August 2013
Hepatitis C transmission & prevention

India: Expert recommendations to tackle viral hepatitis

Editor's pick
Times of India
31 July 2013
Access to healthcare

Activists demand cheaper Hepatitis C drugs

Editor's pick
Jakarta Post
30 July 2013
Access to healthcare

To End Hepatitis C, Patients Must Come Before Profits

Editor's pick
Huffington Post
30 July 2013
Hepatitis C transmission & prevention

Vietnam responses to World Hepatitis Day

Editor's pick
Xinhua
29 July 2013
People who inject drugs

Head of UN drug agency calls for prevention, fair access to treatment on World Hepatitis Day

Editor's pick
UN News Centre
29 July 2013
Hepatitis C treatment

Investigators identify genetic profile associated with better treatment outcomes in people with HIV/HCV co-infection

News
29 July 2013
Experiences of stigma

Hep C stigma as a pharmaceutical marketing device

Editor's pick
Bad Blood (blog)
27 July 2013
Hepatitis C treatment

The time bomb is ticking….Defuse hepatitis C, the viral time bomb!

Editor's pick
HepCoalition
25 July 2013
Hepatitis C treatment

Combining treatments for people who inject drugs is the first step towards eliminating hepatitis C

Editor's pick
Medical Xpress
25 July 2013